Literature DB >> 12167470

Nitric oxide supports atrial function in sepsis: relevance to side effects of inhibitors in shock.

Susanna Price1, Timothy W Evans, Jane A Mitchell.   

Abstract

The mechanisms underlying myocardial dysfunction in sepsis remain poorly understood. The theoretical benefits of nitric oxide synthase (NOS) inhibition in reversing the haemodynamic changes that characterise septic shock have not been supported by clinical trials, some of which have demonstrated detrimental myocardial effects. We have therefore assessed the effects of endotoxaemia on NOS enzyme expression as well as a number of functional responses of myocardial tissue from rats. Atrial tissue expressed high levels of mRNA for inducible (i) NOS and released increased levels of nitrite after animals were treated with endotoxin. In parallel, the inotropic response stimulated by isoprenaline was reduced in atria from endotoxin-treated animals, an effect that was reversed when endogenous release of NO was maximised. Our results suggest that myocardial contractility is maintained by NO production and that inhibitors may compromise cardiac output; this may explain the deleterious effects of NOS inhibition on cardiac function in clinical trials.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12167470     DOI: 10.1016/s0014-2999(02)02000-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Nitric oxide effects depend on different mechanisms in different regions of the rat heart.

Authors:  Kursat Derici; Ufuk Samsar; Emine Demirel-Yilmaz
Journal:  Heart Vessels       Date:  2011-02-11       Impact factor: 2.037

2.  Metabolomic profiling of amines in sepsis predicts changes in NOS canonical pathways.

Authors:  Abel Tesfai; Niall MacCallum; Nicholas S Kirkby; Hime Gashaw; Nicola Gray; Elizabeth Want; Gregory J Quinlan; Sharon Mumby; James M Leiper; Mark Paul-Clark; Blerina Ahmetaj-Shala; Jane A Mitchell
Journal:  PLoS One       Date:  2017-08-15       Impact factor: 3.240

3.  The epoxygenases CYP2J2 activates the nuclear receptor PPARalpha in vitro and in vivo.

Authors:  Jessica A Wray; Mary C Sugden; Darryl C Zeldin; Gemma K Greenwood; Salma Samsuddin; Laura Miller-Degraff; J Alyce Bradbury; Mark J Holness; Timothy D Warner; David Bishop-Bailey
Journal:  PLoS One       Date:  2009-10-12       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.